Topic: monoclonal antibodies

The Companion Animal Arthritis Market has emerged as a critical segment within the veterinary healthcare industry, driven by the growing prevalence of arthritis among pets and the increasing awareness of pet owners regarding the management of chronic conditions. This report provides insights into key aspects of the market, including key takeaways, market drivers, current challenges, SWOT analysis, and the impact of geographical regions on the Companion Animal Arthritis Market. The Global Comp...

The Companion Animal Arthritis Market has emerged as a significant segment within the veterinary healthcare industry, driven by the increasing prevalence of arthritis among pets and the growing awareness regarding the management of this condition. This report aims to provide insights into key takeaways, opportunities, market drivers, and global expansion trends shaping the Companion Animal Arthritis Market. The Global Companion Animal Arthritis Market size is expected to reach US$ 6.31 Bn by ...

The biopharmaceutical industry focuses on developing medications and medical therapies through the use of living cells and organisms. Often referred to as biologics or biologic drugs, biopharmaceuticals help treat a wide range of diseases like cancer, autoimmune disorders, blood-related conditions, and more. Some key types of biopharmaceuticals include vaccines, blood and blood components, allergenics, somatic cells, gene therapies, tissues, and recombinant therapeutic proteins. Vaccines stim...

The coronavirus treatment drugs market comprises drugs being used for treating Covid-19 infections. Some of the key drugs available are antiviral medications that target the virus directly by interfering with viral replication or suppressing the overactive immune response in severe cases. While supportive care remains the mainstay treatment for most patients, the drugs like Remdesivir by Gilead Sciences and Favipiravir by Fujifilm have shown encouraging results for hospitalized patients with mod...

The biologics market involves manufacturing of drugs derived from living cells and organisms. These drugs include monoclonal antibodies, therapeutic proteins, blood components, live attenuated & whole cell vaccines and gene therapies. Biologics are increasingly being used for treating various chronic and complex diseases like cancer, diabetes, autoimmune disorders and cardiovascular ailments. They work by modulating the immune system or mimicking natural biological processes in the human body. T...

What are Biologics? Biologics, also known as biological medicines or biopharmaceuticals, are medicines made from living organisms or contain components of living organisms. They are often large, complex molecules and are very different from most other drugs. Biologics are usually proteins but can also include genes, tissues, cells or vaccines. Most biologics are made from human, animal or microbial cells. Some key examples include vaccines, blood and blood components, allergenics, somatic cel...

Immuno-oncology drugs help enhance the body's natural defenses to fight against cancer. These drugs work by stimulating the immune system to attack cancer cells by releasing immune checkpoints which acts as brakes on immune response. Drugs such as anti-PD-1, anti-CTLA4, and anti-PD-L1, are being increasingly used in cancer treatment to provide targeted therapy and act as checkpoint inhibitors. The global immuno-oncology drugs market is estimated to be valued at US$ 1020.24 Bn in 2023 and is exp...

  The biopharmaceutical industry involves development and production of medications derived from living organisms. Biopharma buffers play a vital role in maintaining optimal pH during various bioprocessing steps such as cell cultivation, purification, and formulation. They help stabilize proteins and prevent denaturation, ensuring maximum yield and efficacy of biologic drugs. The global biopharma buffer market is estimated to be valued at US$ 3.68 Bn in 2023 and is expected to exhibit a CA...

Cancer immunotherapy focuses on harnessing the power of the immune system to detect and destroy cancer cells. With immunotherapy, scientists are developing treatments that help the immune system fight cancer. Examples of such immunotherapies include cancer vaccines, monoclonal antibodies, checkpoint inhibitors, and CAR T-cell therapies. These therapies hold promise because the immune system could provide long-lasting protection against the recurrence of cancer. The global cancer immunotherapy...